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Indicator Definition Population Value (95%CI) N 
Average coverage per cycle Mean of coverage in 
cycles 1,2,3 and 4 
Children aged 3-59 
months at cycle 1. 
73.4% 
(61.0,85.8) 
1180 
Mean number of 
treatments per child 
Mean number of SMC 
treatments received  
Children aged 3-59 
months at cycle 1.  
2.93 
(2.44,3.43)  
1180 
Coverage of 4 cycles % received 4 treatments Children aged 3-59 
months at cycle 1.  
62.6% 
(49.2,74.3)  
1180 
Adherence % received 3 doses at 
last cycle 
Children aged 3-59 
months at cycle 4 
73.4% 
(58.3,84.5)  
1226 
Reach of SMC programme % who received at least 
one treatment 
Children aged 3-59 
months at cycle 1.  
79.0% 
(62.9,89.2) 
1180 
Coverage of cycle 1 % treated at cycle 1 Children aged 3-59 
months at cycle 1.  
73.4% 
(59.2,83.9) 
1180 
Coverage of cycle 2 % treated at cycle 2 Children aged 3-59 
months at cycle 1.  
76.4% 
(61.5,86.8) 
1180 
Coverage of cycle 3 % treated at cycle 3 Children aged 3-59 
months at cycle 1.  
73.5% 
(59.2,84.2) 
1180 
Coverage of cycle 4 % treated at cycle 4 Children aged 3-59 
months at cycle 1.  
70.1% 
(55.9,81.3) 
1180 
Treatment of older children Mean number of SMC 
treatments received 
Children aged 6-7yrs at 
the survey 
1.68 
(0.92,2.45) 
189 
Awareness of SMC dates % households heard 
date before last cycle 
All households 88.6% 
(78.7,94.3)  
530 
LLIN use in children % slept under an LLIN 
last night 
Children 3-59 months 
who slept in the 
household last night 
43.6% 
(33.2,54.6)  
1226 
LLIN use (all ages) % slept under an LLIN 
last night 
All who slept in the 
household last night 
40.0% 
(30.7,49.9)  
3008 
Access to an LLIN (% of 
population) 
% that could sleep 
under LLIN (if 2/net) 
All who slept in the 
household last night 
35.5% 
(27.8,44.0)  
3008 
% households with an LLIN % households with an 
LLIN 
All households 57.2% 
(46.0,67.7)  
534 
Access to LLIN (% of 
households)  
% households with an 
LLIN for every 2 people 
All households, all who 
slept there last night 
14.7% 
(9.7,21.6) 
534 
Caregiver knowledge about 
SMC 
Mean score out of 10 Carers of children 3-59 
months 
8.0  
(7.6,8.4) 
530 
Reported CHW adherence 
to guidelines 
Mean score out of 8 Carers of a child who 
received SMC last cycle 
7.7  
(7.6,7.9) 
411 
SMC directly observed % of first doses 
administered by CHW 
Children 3-59 months at 
cycle 1 who received 
SMC at last cycle 
98.6% 
(95.1,99.6)  
945 
Interval between cycle 1 
and cycle 2 
Difference between 
median cycle dates 
Dates recorded on SMC 
cards 
34 days 347, 
318 
Interval between cycle 2 
and cycle 3 
Difference between 
median cycle dates 
Dates recorded on SMC 
cards 
57 days 318, 
304 
Interval between cycle 3 
and cycle 4 
Difference between 
median cycle dates 
Dates recorded on SMC 
cards 
32 days 304, 
265 
SMC card at survey % of children with SMC 
card 
Children eligible for 
SMC 
33.8% 
(24.7,44.3) 
1180 
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EXECUTIVE SUMMARY 
Seasonal Malaria Chemoprevention (SMC) was introduced in Guinea in 2015 for children aged 3 
months to 5 years, starting in 6 prefectures in 2015, expanding to 8 prefectures in 2016, and 10 
in 2017. SMC gives children a high level of personal protection from malaria. SMC programmes 
have been associated with substantial reductions in malaria cases and malaria deaths. High 
coverage of four monthly cycles is needed to maximise the impact of this intervention. This 
survey was conducted to assess coverage of SMC in 2017 in the prefectures of Gaoual, Koundara, 
Mali, Lelouma, Labe, Koubia, Tougué, Dinguiraye, Siguiri and Mandiana, where SMC was 
implemented in July, August, October and November of 2017. 1448 children, in 40 clusters, were 
surveyed. Caregivers were interviewed about SMC treatments and the dates of treatments were 
recorded from their SMC card. A listing of all household members was made and each asked 
about use of insecticide-treated bednets. 
 
73.4% of children received SMC at cycle 1, 76.4% at cycle 2, 73.5% at cycle 3 and 70.1% at cycle 
4. The mean number of treatments per child was 2.93 (mean coverage 73.4% per cycle). 
Coverage in cycles 1 to 3 was high in all prefectures except Siguiri where only just over half the 
children received SMC in each of the four cycles. As the population of Siguiri is much larger than 
in the other prefectures, the low coverage in Siguiri reduces the overall mean coverage 
proportionately. 21% of children did not receive any SMC treatments, most of those in three 
prefectures Siguiri, Koundara and Mali. In Gaoual and Koundara where there was a sudden drop 
in coverage at cycle 4. Coverage could be substantially improved by addressing the problems in 
Siguiri, and the problems at cycle 4 in Gaoual and Koundara.  
 
It is essential to organise investigation of the reasons underlying these trends, in time to inform 
planning and training for the 2018 campaigns, so that the results of the survey are put to use for 
continuous improvement.  
 
The consistently high coverage achieved in most areas, supports expansion of the SMC 
programme to other eligible prefectures. Steps should be taken to ensure adequate supplies of 
SMC drugs for all 4 cycles to avoid delays in cycle implementation. The mean coverage per cycle 
of 73.4% implies an increase of 36% in the number of treatments administered would be needed 
to achieve 100% coverage. 
 
40% of all household members slept under a LLIN (long-lasting insecticide-treated net) the night 
before the survey, 57.2% of households owned at least one LLIN, but only 14.7% of households 
had one LLIN for every two persons in the household. Steps should be taken to improve LLIN 
coverage. SMC training should include messages about the importance of using an LLIN. These 
figures are slightly lower than reported by the 2016 MICS, but similar tools were used. 
 
SMC coverage should continue to be monitored. Areas with low coverage, and any new areas of 
SMC implementation, should be surveyed at the end of the 2018 transmission season. In areas 
with high coverage, delivery can be monitored through administrative records (compiled from 
tally sheets and SMC drug utilisation), with a coverage survey every two years. 
  
To ensure the continues success of the SMC programme in Guinea it will be important to put in 
place a system to monitor efficacy of SMC, using case control studies to measure clinical 
protection inn children, combined with monitoring of molecular markers of resistance to SMC 
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drugs in the parasite population. Monitoring of molecular markers can be done most efficiently 
and effectively through antenatal clinics. It will also be important to strengthen 
pharmacovigilance, building on progress made through the ACCESS-SMC project. As well as 
working to strengthen the PV system nationally, safety monitoring can be strengthened in 
selected areas where training and supervision can be provided to ensure that health staff 
recognise events and report suspected adverse drug reactions.  
 
HMIS data on malaria should be regularly assessed to track the impact of the SMC programme 
on malaria cases, and malaria deaths in hospital. As part of the ACCESS-SMC project, data were 
collected on individual malaria cases at selected health facilities, these data are useful because 
they allow more detailed analysis of age distribution and seasonality that is possible with HMIS 
data since the HMIS records cases only on broad age groupings (under 5 and 5 and above), by 
calendar month. It is recommended to continue data collection from  selected ’sentinel’ sites in 
order to permit more detailed analysis of trends. 
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INTRODUCTION 
Malaria is endemic in Guinea, and the leading cause of under-5 deaths. WHO (2017) estimates 
there were 4.8million malaria cases and 9000 malaria deaths in Guinea in 2016 caused by 
Plasmodium falciparum, in a population of 12.4million people. The average prevalence of 
infection by Rapid Diagnostic Test was 53% in rural areas in 2012 (DHS, 2012). The main vectors 
are Anopheles gambiae, An. funestus, An. melas and An. arabiensis. Malaria occurs year-round 
with a highly seasonal pattern in the north. The under-5 mortality rate in Guinea was estimated 
in 2012 to be 101 per 1000 live births (DHS, 2012), with malaria the most common cause of 
death (estimated in 2013 to be responsible for 28% of deaths under 5 years of age (WHO, 2013). 
On December 29, 2015, WHO declared Ebola transmission had ended in Guinea, the epidemic 
caused an estimated 3800 cases and 2500 deaths since the outbreak started in March 2014.  
 
Malaria treatment guidelines require patients suspected to have malaria to be tested before 
being treated. Malaria diagnosis and artemisinin combination treatment (ACT) have been free in 
the public sector for all age groups since 2010 for ACT treatment and since 2012 for diagnosis. 
The first-line antimalarial is amodiaquine-artesunate, except in areas where Seasonal Malaria 
Chemoprevention (SMC)  is used, where it has been replaced with artemether-lumefantrine. 
 
Since 2009, long-lasting insecticide-treated bednets (LLINs) have been provided free of charge to 
all age groups. Intermittent preventive treatment in pregnancy using sulfadoxine-pyrimethamine 
has been recommended since 2005. Indoor Residual Spraying and larviciding are not part of the 
national malaria control strategy. Since 2015, Seasonal Malaria Chemoprevention has been used 
to prevent malaria in children under 5 years of age in the northern part of the country, 
supported by the ACCESS-SMC project, financed by UNITAID, in 2015 and 2016, and by CRS and 
the Global Fund in 2017.    
 
Further details about malaria control in Guinea are provided in the President’s Malaria Intiative 
Malaria Operational Plan for Guinea for 2017 (PMI 2017). 
 
BACKGROUND AND OBJECTIVES 
Seasonal Malaria Chemoprevention (SMC), involves the administration of a treatment course of 
sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3–59 months in 
areas of highly seasonal malaria transmission, for up to four months, to prevent malaria  (WHO 
2013). SMC was introduced in Guinea in 2015 for children aged 3 months to 5 years, in 6 
prefectures, in 8 prefectures in 2016, and 10 prefectures in 2017. This survey was planned to 
assess coverage of SMC in 2017 in the prefectures of Gaoual, Koundara, Mali, Lelouma, Labe, 
Koubia, Tougué, Dinguiraye, Siguiri and Mandiana, which had implemented SMC in July, August, 
October and November of 2017. The survey was conducted in December 2017, training 
December 8-9, piloting Dec 13-15, and survey work Dec 16-30, 2017. Data were uploaded to 
server at LSHTM and analysed in Jan 2018. Meetings were held in Conakry from Jan 31 to Feb 2 
2018 to share preliminary results with the project team in UGANC, with the PNLP, with CRS and 
Global Fund, and with StopPalu and PMI. Additional analyses were prepared in response to 
queries raised, before preparing this draft report on 5 Feb 2018 for circulation among partners. 
This final report incorporating feedback was prepared 21 Feb 2018.  
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SMC involves administration of a course of treatment of sulfadoxine-pyrimethemine plus 
amodiaquine over three days, once per month for four months of the malaria transmission 
season, to prevent malaria illness. Children aged at least 3 months and less than 5 years of age 
are eligible to receive SMC, however children who were under 5 years of age at the first month 
continue to receive all four monthly treatments even if they reach the age of 5 during the 4-
month period of SMC distribution. Each monthly treatment consists of a dose of sulfadoxine-
pyrimethamine and a dose of amodiaquine, administered on the first day, and a dose of 
amodiaquine on each of the next two days. The drugs are distributed by community health 
workers (CHWs) who visit door to door to administer the first day’s doses and leave the blister 
pack with the caregiver with instructions to administer the remaining amodiaquine doses on 
each of the next two days. CHWs check the age of the child and select the appropriate blister 
pack (lower dose for infants, higher dose for children 12-59 month), ask about allergies to SMC 
drugs, check whether the child has been given sulfadoxine-pyrimethamine or amodiaquine or 
any sulfa-containing antibiotic in the last 4 weeks, and check if the child has a fever. Children are 
eligible if they do not have known allergies to the drugs, have not been given amodiaquine of 
sulfa-containing medication in the last 4 weeks, and are not unwell. Children who are unwell 
should be referred to the nearest health centre where they can be appropriately treated, 
including treatment with an ACT if they have malaria. If they do not have malaria, they may 
receive SMC at the clinic. CHWs should also remind caregivers to bring the child to the health 
centre if the child becomes unwell at any time after taking SMC, and that the child can still 
develop malaria and so the guidance to seek treatment promptly in the case of fever should 
continue to be followed, and all household members should sleep under a treated bednet. Each 
course of SMC treatment provides about 90% protection from malaria for 28 days so that four 
treatments one month apart can provide a high degree of personal protection for 4 months. 
Introduction of SMC with high coverage has been found to reduce the incidence of malaria, 
severe malaria, and malaria deaths, substantially. To maximise the impact of the intervention, it 
is important that the first SMC cycle is timed to start at the beginning of the main transmission 
period; cycles should take place at monthly intervals; high coverage of 4 monthly treatments 
should be achieved; and caregivers should ensure children adhere to the daily regimen each 
month. Insecticide treated bednets should continue to be used, SMC should be an additional 
measure not a substitute for bednets. The survey therefore assessed bednet use by children and 
other members of the household. 
 
METHODS 
Sampling:  
Forty settlements were selected from 10 prefectures were SMC was implemented in 2017 in the 
country (Figure 1), with probability proportional to population size based on the 2014 General 
Population and Housing Census (RGPH), and in each selected settlement, in order to minimise 
selection bias, area sampling was used, whereby the settlement was divided into segments, one 
segment chosen at random, and all households in the selected segment included in the survey. 
Data were collected on tablet PCs which automatically selected the segment and recorded the 
GPS location of each dwelling visited. In each household, caregivers of children were asked about 
SMC treatments their child had received, and SMC record cards were inspected and 
photographed. All children aged 3 months to 7 years were included in order to determine 
coverage in the target age group (3 to 59 months) and to determine the proportion of children 
just above the recommended age limit who received treatment.  
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In addition, all persons who slept in the household the night before the survey were listed, all 
bednets owned by the household were also listed and inspected, and for each person, the net 
they slept under, if any, was noted.  
 
Figure 1: Prefectures of Guinea (left) and the location of SMC Coverage survey clusters (right). 
(Note there are 40 clusters: Dinguiraye 4, Gaoual 3, Koubia 1, Koundara 2, Labe 5, Lelouma 2, 
Mali 5, Mandiana 5, Siguiri 11, Touge 2). 
  
 
 
Training, piloting and data collection:  
A total of 18 interviewers were trained from 8-9 December 2017, the training included survey 
context and objectives, methods for household selection, seeking consent, and completion of 
the questionnaires, which included a household roster and bednet use by each member of the 
household, questions about the household, about each caregiver, and about each child aged 3 
months to 7 years, and  photographing the SMC record card.  A pilot survey was conducted over 
two days (14 and 15 December 2017) to test the survey tools and practice using them before the 
main data collection. Data were collected on tablet PCs (Google Nexus) using the Dharma 
platform, with three separate forms (Household roster; bednet survey; and SMC coverage). A 
roster of all persons who slept in the household the night before the survey was made, a list of 
all bednets made, and each person asked if they slept under a net and if so which net. Household 
level questions included socioeconomic status and awareness about the SMC programme; one 
caregiver in each household was asked about their knowledge about SMC and about the process 
that the CHW went through during SMC administration and about the time and any costs that 
were involved in receiving SMC. Each caregiver was asked about their age, marital status and 
level of education and for each child aged from 3 months to 7 years, questions about SMC were 
asked and details of SMC treatments captured from the SMC card, which was also 
photographed. Data collection was carried out by 12 fieldworkers, organised in 5 teams each 
assisted by a local guide, overseen by two supervisors. Data collection took place from 16-30 
December 2017. Two supervisors provided close supervision to the 05 teams place from 13 
December to 30 December 2017. The software Dharma Platform Version 1.001 (November 2017) was 
used, with forms for SMC coverage surveys developed by LSHTM. Data were uploaded to a server, 
incorporated into an Access database, and analysed using Stata version 14 (Stata corp, Texas, 
USA).  
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RESULTS 
Response rates 
A total of 534 households participated in the survey (Table 1), 95% of all households visited. The 
location of the clusters is shown in Figure 1. A total of 1448 children were included, of these 
1226 were aged 3-59 months at the time of cycle 4 and hence eligible to be treated at cycle 4, 
and 1180 were aged at least 3 months at the time of cycle 1 and were under 5 years at the 
survey and so were eligible to have receive 4 SMC treatments. 189 children were aged 6-7 years 
when the survey was done and so were above 5 years of age at the time of SMC cycle 1. 
 
Table 1: Response rates and the number of households, children and other household members 
surveyed: 
Households surveyed:  No. of households %  
Agreed to participate 534 94.68% 
No children of eligible age 13 2.30% 
Refused to participate 1 0.18% 
Unable to find someone to speak with 16 2.84% 
TOTAL 564   
Children surveyed: No. of children  
Aged 3-59 months at cycle 4 (eligible for SMC at cycle 4) 1226  
Aged 3-59 months at cycle 1 (eligible for 4 SMC treatments) 1180  
Aged 5-6 years at survey 30  
Aged 6-7 years at survey (more than 5 years of age at cycle 1) 189  
TOTAL (3 months to 7 years at survey) 1448  
Caregivers surveyed: 616  
   
Total population surveyed: No. of household members  
Slept in the household the night before the survey 3010  
TOTAL 3041  
 
Timing of SMC cycles 
SMC treatments provide a high degree of protection for 28 days, after this time protection 
decreases rapidly. SMC cycles should therefore take place at intervals of about 28 days to ensure 
children remain protected. Cycle 1 took place in July, cycle 2 in August, the third cycle, which was 
delayed due to a shortage of SMC drugs, took place in October, and the last cycle in November 
(Figure 2). The intervals between the median dates of the cycles as recorded on SMC cards, was 
34 days between cycle 1 and cycle 2, 57 days between cycle 2 and cycle 3, and 32 days between 
cycle 3 and cycle 4. 
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Figure 4: Timing of SMC cycles 
 
Awareness about the SMC campaign 
Caregivers need to be aware of the purpose of the SMC programme and need to know the day 
when SMC will be distributed in their area in order to ensure they are available on that day. 
91.3% of households knew about SMC; before the last cycle, 88.6% of them had heard the date 
when CHWs would come. In two prefectures, Gaoual and Koundara, it appears communication 
about SMC cycle 4 was less effective, in Gaoual only 49.1% of households knew the date of cycle 
4 and in Koundara, 16.9%. The common sources of information about SMC varied: criers in 
Koubia, Siguiri and Touge; the mosque or church in Dinguiraye, Mandiana and Siguiri; and from 
health workers in all prefectures. The local radio stations were not fully operational during the 
SMC period which may explain why the radio was less often given as a source of information 
(41.1% heard through the radio).  In Gaoual and Koundara, people heard about the campaign 
from the SMC supervisor, but there was less use of criers. 
 
Figure 5: Public awareness about SMC, and about the dates of the most recent SMC campaign 
(cycle 4), and where caregivers heard about date of the campaign: 
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Table 2: Percentage of households that were aware of the SMC programme, had heard the date 
when cycle 4 would start in their village, and the source of the information 
Prefecture Household 
aware 
about 
SMC  
Heard 
the 
date 
of 
cycle 
4 
From  
friends/ 
neighbour 
From a 
health 
worker 
From 
a 
crier 
From 
posters 
On 
the 
radio 
On 
TV 
At the  
Mosque 
/church 
Other* 
Dinguiraye 100.0 100.0 0.0 100.0 0.0 0.0 100.0 0.0 100.0 0.0 
Gaoual 49.1 49.1 0.0 35.4 10.3 0.0 0.0 0.0 6.2 41.6 
Koubia 100.0 100.0 95.1 80.5 95.1 0.0 50.0 0.0 71.4 0.0 
Koundara 21.1 16.9 1.9 14.9 9.3 0.0 25.3 0.0 4.2 18.7 
Labé 96.9 84.1 60.4 90.3 30.5 3.4 35.2 10.2 32.2 0.0 
Lelouma 100.0 100.0 28.7 85.8 12.2 0.0 68.9 0.0 0.0 0.0 
Mali 88.5 88.7 80.8 80.5 58.9 0.0 50.2 0.0 68.3 0.0 
Mandiana 100.0 100.0 0.0 100.0 0.0 0.0 88.2 12.1 100.0 0.0 
Siguiri 98.0 97.3 49.3 67.8 86.4 0.0 5.2 0.0 96.0 0.0 
Tougé 97.3 100.0 100.0 81.8 82.7 27.2 94.0 8.2 60.1 0.0 
TOTAL 91.3 88.6 39.8 77.7 48.3 2.0 41.1 3.8 66.0 3.3 
*the most common other source of information given was the SMC supervisor 
Caregivers’ knowledge about SMC  
Caregivers were generally well informed about SMC with an average score of 80% on a 10-point 
knowledge questionnaire Table 2, Table 3). 
Table 3: Caregivers’ knowledge about SMC: 
 Question Correct 
response 
1 For how many months should the child take SMC 4 
2 SMC is given to prevent malaria Yes 
3 SMC can prevent other diseases No 
4 How many tablets should the child take on the first day? 2 
5 How many tablets should the child take on the second day? 1 
6 How many tablets should the child take on the third day? 1 
7 The child should swallow all the medication Yes 
8 I can give the tablets to someone else who is unwell No 
9 The child should complete the 3-day course of treatment Yes 
10 I should take the child to the health centre if unwell after SMC Yes 
Maximum score: 10 
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Table 4: Caregivers’ knowledge scores on SMC: 
Prefecture Average caregiver knowledge 
score (out of 10) 
Average reported CHW score for 
adherence to guidelines (out of 8) 
Dinguiraye 8.0 8.0 
Gaoual 8.1 8.0 
Koubia 8.4 7.5 
Koundara 6.8 6.1 
Labé 8.7 7.9 
Lelouma 8.8 8.0 
Mali 7.2 7.0 
Mandiana 7.4 8.0 
Siguiri 7.9 8.0 
Tougé 9.3 6.8 
TOTAL 8.0 7.7 
 
Community Health Worker adherence to SMC guidelines, as reported by caregivers 
CHW’s should check the child’s age, and before administering the treatment should ask about 
illness and refer the child if they are unwell, and should check the child has not had severe side 
effects to SMC before. They are also trained to explain to the caregiver how to administer the 
amodiaquine tablets on the next two days, and to advise caregivers about potential side effects 
and to bring the child to a health worker if they are become unwell after SMC. Caregivers of 
children who had received SMC, reported that the CHW generally followed these guidelines 
correctly (Table 4, Figure 4).  
 
Table 5: CHW adherence to guidelines 
 Action % of caregivers who 
reported that the CHW 
performed the action 
at the last visit: 
1 Check the child's age 100.0 
2 Explain how to administer tablets 99.6 
3 Check for illness or fever 98.9 
4 Explain the common side effects of SMC drugs 97.0 
5 Advise to bring the child to the health centre if they are unwell 97.0 
6 Ask if the child had taken other medicines in the last 4 weeks 95.8 
7 Ask if the child had side effects to SMC before 92.9 
8 Ask about allergies to medicines 91.7 
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Figure 6: CHW adherence to guidelines 
 
 
SMC administration at the last cycle before the survey (cycle 4) 
Caregiver’s recall is likely to be most accurate about the last SMC treatment, so a number of 
questions asked specifically about SMC treatment at the fourth cycle. 75.6% of eligible children 
were treated (Table 5), and in 98.6% of treated children, the first dose was administered by the 
CHW (Table 6). In common with other surveys, the reported adherence to the unsupervised 
doses of amodiaquine was very high. A total of 73.4% of children received all three daily doses. 
 
Table 7: Percentage of children who were definitely eligible at cycle 4 (aged 3-59 months), who 
received SMC, and the percentage who received all 3 daily doses: 
Prefecture 
Percentage  
treated 
Percentage who 
received all 3 daily 
doses 
Number of 
children  
aged 3-59 months 
Dinguiraye 100.0 100.0 162 
Gaoual 33.4 33.4 60 
Koubia 91.4 91.4 35 
Koundara 28.2 28.2 41 
Labé 80.3 64.6 148 
Lelouma 91.7 89.1 36 
Mali 74.8 73.3 134 
Mandiana 86.3 86.3 150 
Siguiri 67.0 67.0 399 
Tougé 90.9 90.9 61 
Total 75.6 73.4 1,226 
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Table 8: Out of those who received SMC at cycle 4, the percentage whose first dose was 
administered by the CHW, the percentage that received the second dose, and the percentage 
that received the third dose: 
Prefecture First dose 
administered by the 
CHW 
Second 
dose 
given 
Third dose 
given 
Dinguiraye 100.0 100.0 100.0 
Gaoual 100.0 100.0 100.0 
Koubia 100.0 100.0 100.0 
Koundara 100.0 100.0 100.0 
Labé 91.1 91.9 85.1 
Lelouma 97.2 97.2 100.0 
Mali 100.0 100.0 98.0 
Mandiana 100.0 100.0 100.0 
Siguiri 100.0 100.0 100.0 
Tougé 100.0 100.0 100.0 
TOTAL 98.6 98.8 97.9 
 
The most common reasons for not receiving SMC at cycle 4 were that the child was away, the 
drugs were unavailable, and that the CHW did not visit (Table 7). In the few cases where 
caregivers said they had not administered the second and third amodiaquine doses, the reasons 
given were that they were away, they did not understand that they had to administer the 
amodiaquine, they were too busy, and because the child had side effects (Table 8). 
 
 
Table 9: Reasons for not receiving SMC at cycle 4 
Reason % 
Child was away at the time 33.2 
Stock-out of SMC drugs 25.5 
CHW did not come 18.3 
No reason given 14.2 
Caregiver not available 2.8 
Child too old 2.6 
Child was living away from home 1.5 
Child was unwell 0.8 
CHW did not check child age 0.5 
Child too young 0.3 
Family refused 0.3 
 
Table 10: Reasons for not administering doses 2 and 3 at cycle 4 
Reasons for not giving the dose: Dose 2 Dose 3 
 Carer away Carer away 
 Carer did not understand Carer too busy 
  Child had side effects 
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SMC delivered door-to-door involves few costs to the household but someone responsible has to 
be available when the CHW visits and this may interfere with other activities. 94% of households 
reported that the mother was with the child during the CHW visit. About 20% of households 
reported that they waited more than one hour for the CHW to visit, 31% less than an hour, but 
about half could not say how long they waited. The process of SMC administration in the 
household, once the CHW arrived, was reported by 58% of household to take less than 15 
minutes. 33% could not say how long the process took, but all respondents were able to give an 
approximate rating to the amount of time they had to give up for SMC (very short or short, long 
or very long, etc), only 7.7% rated the time as long, very long, or all day. 
 
Table 11: Percent of Households who waited with the child  
Who waited with the child % of households 
Mother 94.0 
Father 2.32 
Grandmother 2.13 
Grandfather 0.58 
Other 0.46 
Sister 0.26 
Neighbour 0.23 
Aunt 0.03 
 
Table 12: time spent waiting   
 
How do you rate the time spent waiting in total: % of households 
Very short 40.7 
Short 32.6 
Neither short nor long 19.0 
Long 3.6 
Very long 3.5 
All day 0.6 
 
Time spent waiting for the CHW % of households 
Less than 1 hour 30.8 
1-2 hours 11.2 
Up to half a day 5.5 
A full day 2.9 
Don’t know 49.7 
 
Time taken to administer SMC in the household: 
Time taken while CHW was at the compound % of households 
Less than 15 minutes 58.0 
15-30 minutes 4.4 
30 minutes - 1 hour 0.4 
1-2 hours 1.6 
Long wait of more than 2hrs 2.2 
Don’t know 33.4 
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Total number of SMC treatments received by each child 
Children aged 3 to 59 months at the time of cycle 1 are eligible to receive SMC four times, and 
should receive all of these treatments to maximise their protection. The mean number of 
treatments per child was 2.93. 73.4% of children received SMC at cycle 1, 76.4% at cycle 2, 73.5% 
at cycle 3 and 70.1% at cycle 4. 21% of children did not receive any SMC treatments, most of 
those in three prefectures Siguiri, Koundara and Mali. Coverage was similar in all 4 cycles except 
for Gaoual and Koundara where there was a problem at cycle 4 with a sudden drop in coverage. 
Coverage in cycles 1 to 3 was high in all prefectures except Siguiri where only just over half the 
children received SMC in each of the four cycles. As the population of Siguiri is much larger than 
in the other prefectures, the low coverage in Siguiri reduces the overall mean coverage 
proportionately. Coverage could be substantially improved by addressing the problems in Siguiri, 
and the problems at cycle 4 in Gaoual and Koundara. 
 
Table 13: SMC coverage among children eligible for four treatments, by Prefecture:  
  % that received SMC at each cycle: 
Prefecture Mean number of 
treatments 
Cycle 1 Cycle 2 Cycle 3 Cycle 4 
Dinguiraye 3.99 100.0 100.0 100.0 99.3 
Gaoual 3.10 94.2 92.6 86.1 36.7 
Koubia 3.54 82.9 91.4 91.4 88.6 
Koundara 2.49 79.7 79.7 68.1 21.4 
Labé 3.04 72.8 84.2 69.5 77.8 
Lelouma 3.83 94.1 94.1 100.0 94.7 
Mali 2.97 68.9 78.2 70.8 78.7 
Mandiana 3.49 87.7 87.7 86.6 86.6 
Siguiri 2.12 52.6 54.1 54.4 51.2 
Tougé 3.79 92.3 94.7 96.9 95.1 
TOTAL 2.93 73.4 76.4 73.5 70.1 
 
Figure 7: SMC coverage by cycle and prefecture 
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The area covered by the SMC programme increased from 6 prefectures n 2015, to 8 in 2016 and 
10 in 2017. Coverage was slightly higher in 2016 than 2015, despite the increase in area, 
coverage was lower in 2017 than 2016, largely due to the lower coverage in Siguiri. 
 
Table 14: Comparison of coverage with 2015 and 2016: mean number of treatments per child in 
each year 
Prefecture 2015 2016 2017 
Dinguiraye 3.25 3.65 3.99 
Gaoual 2.46 3.29 3.1 
Koubia 3.26 3.52 3.54 
Koundara 3.16 2.75 2.49 
Labé   3.04 
Lelouma   3.83 
Mali 3.20 3.40 2.97 
Mandiana  3.46 3.49 
Siguiri  3.48 2.12 
Tougé 3.50 3.89 3.79 
TOTAL 3.15 3.46 2.93 
 
Figure 8: Comparison of mean number of treatments per child in 2015, 2016 and 2017 
 
SMC distribution was highly equitable, when compared by wealth ranking, the mean number of 
treatments was slightly higher in the poorest group than in the richest (3.18 compared to 2.57). 
Coverage was similar in girls and boys.  
 
Table 15: SMC coverage among children eligible for four treatments, by socioeconomic ranking:  
  % that received SMC at each cycle: 
Wealth 
ranking 
Mean number of 
treatments 1 2 3 4 
Lowest 3.18 84.2 88.0 73.1 72.4 
Low  3.32 83.5 85.8 85.7 77.3 
Middle 2.69 64.8 67.6 69.4 67.2 
High 3.01 75.7 77.5 74.7 73.1 
Highest 2.57 61.9 66.4 66.7 62.1 
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Table 16: SMC coverage among children eligible for four treatments, by gender 
  % that received SMC at each cycle: 
 Mean number of 
treatments 
1 2 3 4 
Male 2.91 73.0 75.8 73.2 68.7 
Female 2.96 73.7 77.0 73.8 71.5 
 
Table 17: Number of SMC treatments: percentage of children who received SMC 0,1,2,3,or 4 
times 
 % children who received SMC 0,1,2,3,4 times 
Prefecture 0 1 2 3 4 
Dinguiraye 0.0 0.0 0.0 0.7 99.3 
Gaoual 3.9 0.0 13.5 47.9 34.7 
Koubia 8.6 0.0 0.0 11.4 80.0 
Koundara 20.3 0.0 11.5 46.8 21.4 
Labé 2.8 8.4 12.8 33.8 42.2 
Lelouma 0.0 0.0 5.9 5.3 88.8 
Mali 18.5 3.3 2.8 13.9 61.5 
Mandiana 12.3 0.0 1.1 0.0 86.6 
Siguiri 45.6 0.0 0.2 4.7 49.4 
Tougé 0.0 0.0 4.6 11.7 83.7 
TOTAL 21.0 1.3 3.4 11.6 62.6 
 
Table 18: Percentage of children by SMC cycles received 
Received SMC at cycle:  
1 2 3 4 % of children 
0 0 0 0 21.0 
0 0 0 1 1.0 
0 0 1 0 0.2 
0 0 1 1 0.8 
0 1 0 0 0.2 
0 1 1 0 0.2 
0 1 1 1 3.2 
1 0 0 1 0.2 
1 0 1 0 0.1 
1 0 1 1 0.2 
1 1 0 0 2.0 
1 1 0 1 2.0 
1 1 1 0 6.2 
1 1 1 1 62.6 
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Treatment of children above the age of 5 
Children who are 5 years of age and above at the time of the first SMC cycle, should not receive 
SMC. The dose has been calculated according to age and if children above the age of 5 are given 
the blister pack intended for the 12-59-month group, they may be under-dosed, this can select 
for resistance as parasites are exposed to sub-therapeutic doses of SMC drugs. Children aged 
above 6 years at the time of the survey, should not have received SMC. 53.8% of this group 
received an SMC card and about 40% received SMC at each cycle.  
 
Table 19: Treatment of children above the age limit for SMC (aged 6-7 years at the survey) 
 Treated at cycle:     
Mean number of 
treatments 
1 2 3 4 Given an SMC 
card 
Number 
surveyed 
1.68 42.8 43.9 43.5 38.2 53.8 189 
 
SMC cards 
89% of eligible children received an SMC card but only 38% had their SMC card available for 
inspection in the survey. Assessment of coverage therefore relied on caregiver recall for those 
who did not have an SMC card. Although agreement between recall and card-documented SMC 
was good, caregivers should be encouraged to retain SMC cards so that they can be inspected. 
 
Table 20: Percentage of eligible children who received an SMC card, and the percentage with a 
card available for inspection during the survey 
Prefecture Given SMC card Card available for inspection 
Dinguiraye 100.0 3.6 
Gaoual 92.6 37.1 
Koubia 91.4 68.8 
Koundara 73.9 22.5 
Labé 86.0 69.3 
Lelouma 97.3 73.6 
Mali 81.5 60.6 
Mandiana 87.1 37.5 
Siguiri 87.7 25.8 
Tougé 98.5 76.5 
TOTAL 89.0 38.0 
 
Table 21: Agreement between caregiver report and SMC card: 
Cycle Card 0 Carer 0 Card 1 Carer 1 Card 0 Carer 1 Card 1 Carer 0 % agreement kappa 
1 32 377 6 48 88.34 0.4851 
2 23 401 9 30 91.58 0.4979 
3 35 390 9 29 91.79 0.6035 
4 47 378 6 32 91.79 0.6664 
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Bednet use by children and other household members 
Bednet use was recorded in the survey for children receiving SMC and for all members of the 
household. Insecticide-treated bednets are the most cost-effective method of malaria 
prevention, SMC adds to this protection but does not replace the need to use bednets (ITNs or 
LLINs (long-lasting insecticide-treated nets). 43.6% of children in the survey (childen eligible to 
receive SMC) were reported to have slept under a bednet (of any type) the night before the 
survey. 40.6% of all household members slept under a net the night before the survey, almost all 
of these were LLINs. Females were most likely to use a net than males (43.4% compared to 
35.8%). 57.2% of households owned at least one LLIN, but only 14.7% of households had one 
LLIN for every two persons in the household. 
 
Table 22: Percentage of children 3-59months who slept under a bednet (of any type) the night 
before the survey 
Prefecture Slept under a net (of any type) last night 
Dinguiraye 20.9 
Gaoual 93.3 
Koubia 88.6 
Koundara 93.5 
Labé 75.2 
Lelouma 31.1 
Mali 77.7 
Mandiana 36.6 
Siguiri 19.6 
Tougé 55.9 
TOTAL 43.6 
 
Table 23: Percentage who slept under a bednet, out of those who slept in the household the 
night before the survey, by prefecture 
Prefecture Any net LLIN Intact net Net <2yrs old No. surveyed 
Dinguiraye 20.3 19.6 0.0 19.6 281 
Gaoual 92.2 89.8 78.2 0.0 165 
Koubia 72.5 66.7 49.0 66.7 102 
Koundara 82.2 82.2 59.0 0.0 102 
Labé 65.4 64.6 1.8 51.3 450 
Lelouma 28.7 28.7 0.0 18.3 100 
Mali 68.3 68.3 54.5 52.2 375 
Mandiana 30.8 30.2 5.4 29.9 302 
Siguiri 16.7 16.2 15.4 0.3 936 
Tougé 48.5 48.5 24.1 21.0 197 
TOTAL 40.6 40.0 20.8 21.6 3,010 
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Table 24: Percentage who slept under a bednet, out of those who slept in the household the 
night before the survey, by age group 
Age  Any net LLIN Intact net Net <2yrs old No. surveyed 
<10yrs 40.5 39.8 20.0 21.7 1,619 
10-14yrs 38.1 37.5 23.8 19.8 182 
15-19yrs 35.2 35.2 18.1 17.3 121 
20-24yrs 43.8 43.4 21.7 26.9 131 
25-29yrs 43.7 42.8 21.0 19.1 216 
30-39yrs 40.6 39.9 22.1 21.4 358 
40+yrs 41.4 40.3 22.5 23.8 383 
TOTAL 40.6 40.0 20.9 21.7 3,010 
 
Table 25: Percentage who slept under a bednet, out of those who slept in the household the 
night before the survey, by wealth ranking 
Wealth ranking Any net LLIN Intact net Net <2yrs old No. surveyed 
Lowest 48.7 47.3 21.1 25.5 480 
Low  47.0 45.4 22.0 24.9 520 
Middle 40.7 40.7 26.2 23.8 571 
High 32.6 32.1 13.6 20.2 663 
Highest 41.1 40.8 24.8 17.2 743 
 
Table 26: Percentage who slept under a bednet, out of those who slept in the household the 
night before the survey, by gender 
Gender Any net LLIN Intact net Net <2yrs old No. surveyed 
Male 36.4 35.8 18.0 19.6 1,388 
Female 44.2 43.4 23.3 23.4 1,622 
 
Table 27: Percentage of the population who could sleep under a net if two people slept under 
each net: (values in the main part of the table are row percentages) 
 No. of nets in the household (of any type):   
No. who 
slept in 
the 
household 
last night  
0 1 2 3 4 5 6 7 No. of 
households 
% could 
sleep 
under net 
if 2/net 
1         0  
2 21.8 62.4 15.8 0.0 0.0 0.0 0.0 0.0 21 78.2 
3 34.1 50.8 13.0 2.2 0.0 0.0 0.0 0.0 63 49.0 
4 43.3 31.6 20.6 1.9 2.6 0.0 0.0 0.0 95 40.9 
5 35.8 32.5 25.8 4.8 1.1 0.0 0.0 0.0 102 39.5 
6 44.6 17.9 22.8 13.0 1.0 0.7 0.0 0.0 90 35.9 
7 53.1 11.7 17.6 11.7 5.9 0.0 0.0 0.0 72 29.3 
8+ 48.8 11.6 12.4 10.5 9.1 2.1 3.4 2.0 86 29.1 
Total 42.5 26.9 19.1 7.0 3.1 0.5 0.6 0.3 529 35.6 
(The number that could sleep under a net is min(no. who slept in the household, no. of netsx2).) 
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Table 28: Percentage of the population who could sleep under a LLIN if two people slept under 
each net: (values in the main part of the table are row percentages) 
 No. of nets in the household (LLINs):   
No. who 
slept in 
the 
household 
last night 
0 1 2 3 4 5 6 7 No. of 
households 
% could 
sleep 
under net 
if 2/net 
1         0  
2 21.8 62.4 15.8 0.0 0.0 0.0 0.0 0.0 21 78.2 
3 34.1 50.8 13.0 2.2 0.0 0.0 0.0 0.0 63 49.0 
4 43.3 31.6 20.6 1.9 2.6 0.0 0.0 0.0 95 40.9 
5 36.8 31.6 25.8 4.8 1.1 0.0 0.0 0.0 102 39.1 
6 44.6 17.9 22.8 13.0 1.0 0.7 0.0 0.0 90 35.9 
7 53.1 11.7 17.6 11.7 5.9 0.0 0.0 0.0 72 29.3 
8+ 48.8 11.6 12.4 11.7 8.0 2.1 3.4 2.0 86 28.9 
Total 42.6 26.7 19.1 7.2 2.9 0.5 0.6 0.3 529 35.5 
 
Table 29: Percentage of households with at least one net, and percentage of households with at 
least one net for every two people who slept in the household the night before the survey 
 Net of any type LLIN Intact net Net <2yrs old  
Prefecture 1 or  
more 
At least  
1 per 2 
1 or  
more 
At least  
1 per 2 
1 or  
more 
At least  
1 per 2 
1 or  
more 
At least  
1 per 2 
No. of 
households 
Dinguira 27.5 0.0 27.5 0.0 0.0 0.0 27.5 0.0 40 
Gaoual 97.5 56.5 97.5 56.5 94.9 45.2 0.0 0.0 36 
Koubia 92.9 7.1 92.9 7.1 92.9 0.0 92.9 7.1 14 
Koundara 83.1 46.4 83.1 46.4 64.5 38.0 0.0 0.0 22 
Labé 85.8 20.5 85.8 20.5 9.1 0.0 73.3 14.6 103 
Lelouma 47.3 23.2 47.3 23.2 5.4 0.0 41.9 8.9 21 
Mali 76.6 20.9 76.6 20.9 63.3 16.6 62.2 16.6 66 
Mandiana 40.7 4.4 39.2 4.4 6.1 0.0 39.5 4.4 58 
Siguiri 30.4 2.8 30.4 2.8 29.8 2.2 1.2 0.0 141 
Tougé 75.8 18.1 75.8 18.1 58.3 5.5 31.4 6.6 33 
Total 57.4 14.7 57.2 14.7 31.9 6.9 32.9 5.9 534 
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RECOMMENDATIONS 
1) High coverage of SMC has been achieved in most prefectures in most cycles. SMC 
distribution door to door is highly equitable with good coverage in the poorest sections of 
the community. Despite the challenges of SMC delivery, the programme is effective, this 
should encourage expansion of the SMC programme to other prefectures. 
2) In areas with poor coverage (Siguiri in all cycles, and Gaoual and Koundara in cycle 4), the 
reasons should be investigated and steps taken to resolve the problems. Because Siguiri 
has a large population the low coverage there has a proportionately large effect on 
overall coverage figures.  
3) SMC treatment provides a high degree of protection for 4 week but protection falls off 
rapidly in the 5th week, it important therefore to ensure adequate supplies of drugs to 
complete all four cycles on schedule. 
4) In some areas caregivers had not heard of the dates of SMC campaigns, steps to improve  
communication, through greater use of criers and other channels such as local radio and 
mosques and churches, should be taken. 
5) SMC training should emphasise the importance of checking the age of the child to avoid 
treating children above the age of 5. The child-strength blister packs are not suitable for 
children above 5 years of age.  
6) LLIN coverage was low. Reasons behind this should be explored and steps taken to 
improve LLIN coverage. CHWs distributing SMC should be trained to remind caregivers 
the importance of sleeping under an LLIN. Estimates of LLIN coverage from this survey 
are slightly lower than in the 2016 MICS (44.8% Kankan, 61.5% Labe, 54% Boke, 52.8% 
Faranah). 
7) SMC coverage should continue to be monitored. Areas with low coverage, and any new 
areas of SMC implementation, should be surveyed at the end of the 2018 transmission 
season. In areas with high coverage, delivery can be monitored through administrative 
records (compiled from tally sheets and SMC drug utilisation), with a coverage survey 
every two years. 
8) It will be important to put in place a system to monitor efficacy of SMC, using case 
control studies to measure clinical protection inn children, combined with monitoring of 
molecular markers of resistance to SMC drugs in the parasite population. Monitoring of 
molecular markers can be done most efficiently and effectively through antenatal clinics. 
It will also be important to strengthen pharmacovigilance, building on progress made 
through the ACCESS-SMC project. As well as working to strengthen the PV system 
nationally, safety monitoring can be strengthened in selected areas where training and 
supervision can be provided to ensure that health staff recognise events and report 
suspected adverse drug reactions. 
 
9) HMIS data on malaria should be regularly assessed to track the impact of the SMC 
programme of malaria cases and malaria deaths. As part of the ACCESS-SMC project, data 
were collected on individual malaria cases at selected health facilities, these data are 
useful because they allow more detailed analysis of age distribution and seasonality that 
is possible with HMIS data since the HMIS records cases only on broad age groupings 
(under 5 and 5 and above), by calendar month. It is recommended to continue data 
collection from  selected ’sentinel’ sites in order to permit more detailed analysis of 
trends. 
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Annex: Sampling methods 
The survey was conducted in the prefectures of Gaoual, Koundara, Mali, Lelouma, Labe, Koubia, 
Tougué, Dinguiraye, Siguiri and Mandiana, which had implemented SMC in July, August, October 
and November of 2017. The estimated total population size of the 10 prefectures was 2,570,789 
based on the 2014 census. A sampling interval of 2,570,789/40= 64269.725 was used to select 40 
settlements with probability proportional to size, using systematic sampling from a list of all 
9352 settlements in the 10 prefectures, after sorting by prefecture to give an implicit 
stratification. A rough sketch map of each selected settlement was made showing areas of 
habitation and local landmarks. Each map was then divided into segments of approximately 
equal size, the number of segments being chosen so that one segment would be expected to 
yield approximately the required number of children, based on the estimated total population 
size, while as far as possible taking advantages of local features to facilitate identification of 
segment boundaries on the ground. Children aged at least 3 months at SMC cycle 1, (hence at 
least 7 months at the time of the survey, conducted one month after cycle 4) and less than 7 
years at the time of the survey, were eligible to be included. It was assumed that this age group 
represents about 20% of the total population. A total sample size of about 1000 children was 
required, i.e. 1000/40=25 children on average from each village. Each village was therefore 
divided into S=floor(Nix0.2/25) segments, where Ni was the population from the 2014 census. 
The segments were numbered on the map and then the number of segments created was 
entered into a tablet PC which used simple random sampling to select a segment number to be 
surveyed. Every dwelling within the chosen segment was then visited and every child between 
the age of 7 months and 7 years, who had stayed in the house the night before the survey, was 
included in the survey. The GPS location of each dwelling visited was automatically recorded by 
the tablet PC used to collect interview data. The number surveyed in each settlement therefore 
could vary but the average was expected to be about 25 if the population data were accurate. 
There were eight settlements that were selected which were too large for segmentation to be 
practical, and there was no information available about sub-divisions of these segments that 
could be used to select a smaller area. For these settlements, the total area was estimated by 
taking GPS locations around the perimeter of the inhabited area. A single location was then 
chosen, by randomly generating an x and y coordinate within the settlement (this was done 
independently of the survey team and the location sent to them by email). Interviewers 
surveyed houses around this point, recording the GPS location of each dwelling, and continuing 
outwards, without missing any dwellings, until the required number of children (25) had been 
reached. In the final dwelling, all children eligible for the survey were included so the final 
sample size could exceed 25.  
 
In villages which were segmented, the sampling probability is pi=40x(Ni/NT)x(1/S), for individuals 
in settlement i. Here, Ni is the population of village i from the 2014 census and NT is the total 
population of the 10 prefectures. In villages which were too large to segment, it was assumed 
population density was uniform, so the sampling probability is 40x(Ni/NT)x(ai/Ai), where ai is the 
sampled area in village i calculated from the convex hull of the coordinates of dwellings that 
were visited and the start point, and Ai is the total area of the settlement. The sampling weight 
for each child (the number of children in the population that each child surveyed represents) was 
1/pi. 
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Standard errors of estimates of indicators were computed using linearized variance formulae for 
ratio estimators. For binary variables, confidence intervals for proportions were obtained after 
using a logit transformation, to ensure the confidence limits fell in the range (0,1). 
Table A1: List of clusters 
Region Prefecture Sousprefecture Quartier Settlement 
KANKAN DINGUIRAYE Banora Boubèrè Boubèrè Centre 
KANKAN DINGUIRAYE Diatifere Mamoudouya I Bandianya 
KANKAN DINGUIRAYE Dinguiraye-centre Tinkisso Souloukoufalan 
KANKAN DINGUIRAYE Selouma Selouma Centre Sakabari 
KANKAN MANDIANA Balandougouba Sidikila II Sidikila II Centre 
KANKAN MANDIANA Dialakoro Samory Touré Samory TOURE 
KANKAN MANDIANA Kinieran Mbalia Mbalia Centre 
KANKAN MANDIANA Koundian Koundian I Namafouada 
KANKAN MANDIANA Morodou Samakofara Samakofara Centre 
KANKAN SIGUIRI Doko Kouremalé Kouremalé Centre 
KANKAN SIGUIRI Franwalia Franwalia Centre Franwalia Centre 
KANKAN SIGUIRI Kintinian Balato III Balato Centre III 
KANKAN SIGUIRI Kintinian Fatoya Fatoya Centre 
KANKAN SIGUIRI Malea Maléah Centre Maléah Centre 
KANKAN SIGUIRI Niagassola Kignekourou Faraboloni 
KANKAN SIGUIRI Norassoba NanenTraoré Nanen Traoré Centre 
KANKAN SIGUIRI Siguiri-centre Dankakoura Dankakoura Centre 
KANKAN SIGUIRI Siguiri-centre Saourou Saourou Centre 
KANKAN SIGUIRI Siguiri-centre Sougoula Sougoula Centre 
KANKAN SIGUIRI Siguirini Talabé Talabé Centre 
LABE GAOUAL Foulamory Tabadian Nyor Nyor 
LABE GAOUAL Koumbia Dara Bowé Dara Bowé Centre 
LABE GAOUAL Malanta Kounsi Peguéty 
LABE KOUBIA Matakaou Matakaou Centre Dougouwoulen 
LABE KOUNDARA Guingan Kifaya Angona 
LABE KOUNDARA Sambailo Sambailo Centre Thiuopoutel 
LABE LABE Garambe Garambé Centre Bassanya II 
LABE LABE Labé centre Daka II Secteur II 
LABE LABE Labé centre Madina Dianyabhè Mosquée 
LABE LABE Noussy Kassangui Dow Kougue 
LABE LABE Tountouroun Tounny Gadha Thiolliwel 
LABE LELOUMA Lafou Bombi Bourou Yalaya 
LABE LELOUMA Sagale Bamikountou Gnekori 
LABE MALI Donghol Sigon Dougaya Dioma Roundé 
LABE MALI Fougou Kansaghel Laami 
LABE MALI Madina Wora Pellissaré Donghol Doubhi 
LABE MALI Salambande Koya Koya Centre 
LABE MALI Yembereng Sinthiourou Diaguitarè 
LABE TOUGUE Konah Bourouwal Kounsen 
LABE TOUGUE Tougue centre Tougué I Dioloki 
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Table A2: Sampling weights 
Settlement Population 
(2014 census) 
No. of 
segments 
Area of  
settlement  
(m2) 
Area  
surveyed  
(m2) 
Sampling 
probability 
Weight 
Boubèrè Centre 793 7   0.00176 567.32 
Bandianya 531 5   0.00165 605.18 
Souloukoufalan 257 2   0.00200 500.15 
Sakabari 557 5   0.00173 576.93 
Sidikila II Centre 3616 36   0.00156 639.85 
Samory TOURE 3794 37   0.00160 626.77 
Mbalia Centre 12710  1807561 6643 0.00073 1375.91 
Namafouada 131    0.00204 490.61 
Samakofara Centre 1199 11   0.00170 589.63 
Kouremalé Centre 8784  2585632 13099 0.00069 1444.20 
Franwalia Centre 5807  1128427 31777 0.00254 393.02 
Balato Centre III 6354  1202149 21979 0.00181 553.22 
Fatoya Centre 11449  1830130 14269 0.00139 720.00 
Maléah Centre 2245 22   0.00159 629.81 
Faraboloni 436 4   0.00170 589.63 
Nanen Traoré Centre 4362  1086426 8944 0.00056 1789.74 
Dankakoura Centre 1734 17   0.00159 630.10 
Saourou Centre 4372  297145 4635 0.00106 942.45 
Sougoula Centre 2362 23   0.00160 625.83 
Talabé Centre 648 6   0.00168 595.09 
Nyor Nyor 668 6   0.00173 577.27 
Dara Bowé Centre 1315 13   0.00157 635.37 
Peguéty 247 2   0.00192 520.40 
Dougouwoulen 334 3   0.00173 577.27 
Angona 87 1   0.00135 738.73 
Thiuopoutel 497 4   0.00193 517.26 
Bassanya II 644 6   0.00167 598.79 
Secteur II 7182  741157 67814 0.01022 97.80 
Dianyabhè Mosquée 1525 15   0.00158 632.16 
Dow Kougue 16 1   0.00025 4016.86 
Gadha Thiolliwel 174 1   0.00271 369.37 
Yalaya 103 1   0.00160 623.98 
Gnekori 85 1   0.00132 756.11 
Dioma Roundé 413 4   0.00161 622.47 
Laami 121 1   0.00188 531.15 
Donghol Doubhi 131 1   0.00204 490.61 
Koya Centre 139 1   0.00216 462.37 
Diaguitarè 113 1   0.00176 568.76 
Kounsen 234 2   0.00182 549.31 
Dioloki 285 2   0.00222 451.02 
 
Population 3 months to 7yrs of age: unweighted 1,484; weighted 938,345. 
Total population (all ages, slept in the household the night before the survey): unweighted 
3,010; weighted 1,874,896. Census estimate (2014) total population: 2,570,789.  
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Table A3: Standard error, design effect and rate of homogeneity for the main indicators 
Indicator Value s.e. 95%CI Deff Deffweight Deffcluster roh b 
Mean number of 
treatments per child 
2.93 0.247 2.44,3.43 27.55 1.173 23.48 0.579 39.81 
Coverage of 4 cycles 0.626 0.063 0.492,0.743 20.22 1.287 15.71 0.308 48.74 
Adherence 0.734 0.066 0.583,0.845 26.94 1.381 19.51 0.467 40.63 
Reach of SMC programme 0.790 0.065 0.629,0.892 30.12 1.217 24.76 0.612 39.81 
Coverage of cycle 1 0.734 0.062 0.592,0.839 23.06 1.177 19.59 0.479 39.81 
Coverage of cycle 2 0.764 0.063 0.615,0.868 25.99 1.194 21.76 0.535 39.81 
Coverage of cycle 3 0.735 0.063 0.592,0.842 23.74 1.391 17.07 0.414 39.81 
Coverage of cycle 4 0.701 0.064 0.559,0.813 22.93 1.222 18.77 0.458 39.81 
Awareness of SMC dates 0.886 0.037 0.787,0.943 7.24 1.501 4.82 0.220 18.39 
LLIN coverage in children 0.432 0.053 0.329,0.542 13.61 1.179 11.55 0.272 39.81 
LLIN coverage (all ages) 0.400 0.048 0.307,0.499 28.95 1.147 25.25 0.251 97.64 
Proportion that could 
sleep under LLIN (if 2/net) 
0.355 0.040 0.278,0.440 21.43 1.149 18.65 0.183 97.64 
Proportion of households 
with an LLIN 
0.574 0.055 0.461,0.679 6.50 1.232 5.28 0.245 18.47 
Proportion of households 
with a 1 LLIN per 2 people 
0.148 0.030 0.098,0.218 3.64 0.958 3.80 0.160 18.47 
Caregiver knowledge 
about SMC 
8.0 0.201 7.6,8.4 4.82 1.188 4.06 0.176 18.39 
Reported CHW adherence 
to guidelines 7.2 0.083 7.6,7.9 3.76 0.884 4.25 0.163 20.87 
SMC directly observed 0.826 0.066 0.653,0.923 36.84 1.266 29.10 0.709 40.63 
 
The rate of homogeneity, roh, was calculated as (Deffcluster-1)/(b-1), where Deffcluster is the design 
effect due to clustering, calculated from the overall design effect, and the design effect due to 
weighting, Deffclustering= Deffoverall/ Deffweighting, and b is the weighted mean cluster size, 
b=∑n i
2/∑n i (where ni is the number of respondents in cluster i). 
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Figure A1: Example of a cluster showing GPS location of dwellings surveyed 
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Figure A2: Regions, prefectures and sous-prefectures of Guinea 
 
 
1.Beyla 13.Gaoual 25.Macenta 
2.Boffa 14.Guéckédou 26.Mali 
3.Boké 15.Kankan 27.Mamou 
4.Conakry 16.Kérouané 28.Mandiana 
5.Coyah 17.Kindia 29.Nzérékoré 
6.Dabola 18.Kissidougou 30.Pita 
7.Dalaba 19.Koubia 31.Siguiri 
8.Dinguiraye 20.Koundara 32.Télimélé 
9.Dubréka 21.Kouroussa 33.Tougué 
10.Faranah 22.Labé 34.Yomou 
11.Forécariah 23.Lélouma 
12.Fria 24.Lola 
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